MORGAN STANLEY PLC/CALL/CVS HEALTH/130/0.1/20.06.25 Share Price

Warrant

DE000MG0XGL3

Market Closed - Börse Stuttgart 12:12:24 05/06/2024 am IST
0.03 EUR -3.23% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/130/0.1/20.06.25
Current month+3.45%
1 month+11.11%
Date Price Change
05/24/05 0.03 -3.23%
03/24/03 0.031 +6.90%
31/24/31 0.029 +11.54%
30/24/30 0.026 -3.70%
29/24/29 0.027 +58.82%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 12:12 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MG0XGL
ISINDE000MG0XGL3
Date issued 27/03/2024
Strike 130 $
Maturity 20/06/2025 (381 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.062
Lowest since issue 0.017
Spread 0.011
Spread %27.50%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.21 USD
Average target price
69.02 USD
Spread / Average Target
+14.63%
Consensus